Up to 80,000 women die each year as a direct cause of preeclampsia – a life-threatening condition that occurs during pregnancy. Kathriona meets Prof Louise Kenny from Metabolomics Ltd who is developing breakthrough technologies that could provide predictive diagnosis of Preeclampsia in early pregnancy and revolutionise prenatal care globally.
Comments